tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
PVLA
Palvella Therapeutics
RESEARCH TOOLSreports

Palvella Therapeutics (PVLA) Income Statement

779 Followers

Palvella Therapeutics Income Statement

Last quarter (Q4 2025), Palvella Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Palvella Therapeutics's net income was $-12.71M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 25.90M$ 31.42M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 23.12M$ 29.05M
Operating Expenses
$ 38.60M$ 14.10M$ 11.87M$ 66.60M$ 80.88M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 2.78M$ 2.37M
EBITDA
$ -35.90M$ -13.12M$ 18.69M$ -30.50M$ -43.37M
Operating Income
$ -38.60M$ -14.10M$ -11.87M$ -43.47M$ -51.83M
Other Income/Expenses
$ -3.11M$ -3.34M$ 30.56M$ 10.20M$ 6.09M
Pretax Income
$ -41.72M$ -17.43M$ 18.69M$ -33.28M$ -45.74M
Net Income
$ -41.72M$ -17.43M$ 18.69M$ -33.28M$ -45.74M
Per Share Metrics
Basic EPS
$ -3.71$ -7.83$ 14.74$ -29.61$ -56.69
Diluted EPS
$ -3.71$ -7.83$ 14.74$ -29.61$ -56.69
Weighted Average Shares Outstanding
 11.25M 2.23M 1.27M 930.35K 806.84K
Weighted Average Shares Outstanding (Diluted)
 11.25M 2.23M 1.27M 930.35K 806.84K
Currency in USD

Palvella Therapeutics Earnings and Revenue History